Join leading industry figures at Biologics 2024 to discussupdates in peptide & oligonucleotide discovery and development to optimise their therapeutic potential. Gaininsight into the latest updates in peptide & oligonucleotide chemistry, formulation & delivery, analytical development,manufacturing, and therapeutic case studies.
Be sure to visit the AmbioPharm booth (#25) to discuss peptide-based drug discovery and development.
FEATURING:
Peptide Synthesis Strategies for Production of Commercial GLP-1 Agonists